Literature DB >> 11344493

Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group.

R Cooper1, Y Khakoo, K K Matthay, J N Lukens, R C Seeger, D O Stram, R B Gerbing, A Nakagawa, H Shimada.   

Abstract

BACKGROUND: Opsoclonus-myoclonus-ataxia (OMA) is a paraneoplastic syndrome that occurs in about 2-3% of all cases of neuroblastoma. The histopathologic characteristics of neuroblastoma tumors associated with this syndrome were evaluated in a series of cases and controls. PROCEDURE: Pathology slides from a total of 54 neuroblastoma tumors were reviewed blindly. They included 13 tumors associated with opsoclonus-myoclonus and 41 age- and stage-matched controls. All tumors were classified into either the favorable (FH) or unfavorable histology (UH) group according to the International Neuroblastoma Pathology Classification (the Shimada system). Grade of lymphocytic infiltration was evaluated and presence or absence of lymphoid follicles was recorded in the individual tumor tissues.
RESULTS: Twelve of 13 cases with opsoclonus-myoclonus were in the FH group. Twelve of 13 cases had diffuse (found in every section prepared from the multiple portions of the primary tumor) and extensive (occupying more than 50% of a single of multiple microscopic fields with x 100 magnification) lymphocytic infiltration with lymphoid follicles. Of the 41 control cases (27 FH and 14 UH tumors), 18 had focal areas of lymphocytic infiltration and six showed lymphoid follicles, but none had diffuse or extensive infiltration in their primary tumors.
CONCLUSIONS: Diffuse and extensive lymphocytic infiltration with lymphoid follicles is a characteristic histologic feature of neuroblastic tumors with opsoclonus-myoclonus. This observation suggests an immune-mediated mechanism for this rare paraneoplastic syndrome. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11344493     DOI: 10.1002/mpo.1139

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  13 in total

1.  Paraneoplastic Opsoclonus-Myoclonus-Ataxia (OMA) syndrome in an adult patient with esthesioneuroblastoma.

Authors:  Dominique Van Diest; Hendrik De Raeve; Jozef Claes; Paul M Parizel; Dirk De Ridder; Patrick Cras
Journal:  J Neurol       Date:  2008-02-04       Impact factor: 4.849

Review 2.  Spontaneous regression of neuroblastoma.

Authors:  Garrett M Brodeur
Journal:  Cell Tissue Res       Date:  2018-01-05       Impact factor: 5.249

Review 3.  Mechanisms of neuroblastoma regression.

Authors:  Garrett M Brodeur; Rochelle Bagatell
Journal:  Nat Rev Clin Oncol       Date:  2014-10-21       Impact factor: 66.675

4.  Neuroblastic tumors associated with opsoclonus-myoclonus syndrome: histological, immunohistochemical and molecular features of 15 Italian cases.

Authors:  Claudio Gambini; Massimo Conte; Gabriella Bernini; Paola Angelini; Andrea Pession; Paolo Paolucci; Alberto Donfrancesco; Edvige Veneselli; Katia Mazzocco; Gian Paolo Tonini; Lizzia Raffaghello; Carlo Dominici; Adriana Morando; Francesca Negri; Anna Favre; Bruno De Bernardi; Vito Pistoia
Journal:  Virchows Arch       Date:  2003-04-23       Impact factor: 4.064

5.  Amplification of N-Myc is associated with a T-cell-poor microenvironment in metastatic neuroblastoma restraining interferon pathway activity and chemokine expression.

Authors:  Julian P Layer; Marie T Kronmüller; Thomas Quast; Debby van den Boorn-Konijnenberg; Maike Effern; Daniel Hinze; Kristina Althoff; Alexander Schramm; Frank Westermann; Martin Peifer; Gunther Hartmann; Thomas Tüting; Waldemar Kolanus; Matthias Fischer; Johannes Schulte; Michael Hölzel
Journal:  Oncoimmunology       Date:  2017-04-28       Impact factor: 8.110

6.  Paraneoplasia, cancer development and immunity: what are the connections?

Authors:  Louis Chesler
Journal:  Nat Rev Cancer       Date:  2014-07       Impact factor: 60.716

7.  Dancing eyes dancing feet syndrome-a report of two cases.

Authors:  P Jasminekalyani; S Saravanan; Sriramakrishnan V; Radha M
Journal:  J Clin Diagn Res       Date:  2014-05-15

Review 8.  The "neuro" of neuroblastoma: Neuroblastoma as a neurodevelopmental disorder.

Authors:  Nancy Ratner; Garrett M Brodeur; Russell C Dale; Nina F Schor
Journal:  Ann Neurol       Date:  2016-04-30       Impact factor: 10.422

9.  Combination of Id2 Knockdown Whole Tumor Cells and Checkpoint Blockade: A Potent Vaccine Strategy in a Mouse Neuroblastoma Model.

Authors:  Lina Chakrabarti; Clifford Morgan; Anthony D Sandler
Journal:  PLoS One       Date:  2015-06-16       Impact factor: 3.240

10.  Neuroblastoma after childhood: prognostic relevance of segmental chromosome aberrations, ATRX protein status, and immune cell infiltration.

Authors:  Ana P Berbegall; Eva Villamón; Irene Tadeo; Tommy Martinsson; Adela Cañete; Victoria Castel; Samuel Navarro; Rosa Noguera
Journal:  Neoplasia       Date:  2014-06       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.